AB Science – Clarification following the February 11, 2022 public hearing of the Enforcement Committee of the French Market Regulator (AMF)

3 years ago

PRESS RELEASE CLARIFICATION FOLLOWING THE FEBRUARY 11, 2022 PUBLIC HEARING OF THE ENFORCEMENT COMMITTEE OF THE FRENCH MARKET REGULATOR (AMF)…

Pharma-Bio Serv Announces Full Year Results and Declares a Special Dividend

3 years ago

DORADO, PUERTO RICO / ACCESSWIRE / February 11, 2022 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a…

Boosh Acquires Beanfields

3 years ago

Vancouver, British Columbia--(Newsfile Corp. - February 11, 2022) - Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77i) ("Boosh" or…

Canadian School Counselling Week 2022: Who We Are and How We Help

3 years ago

Ottawa, Ontario--(Newsfile Corp. - February 11, 2022) - As students across Canada return to in-person schooling during another school year…

NLS Pharmaceutics to Participate in 2022 BIO CEO & Investor Conference

3 years ago

ZURICH, SWITZERLAND / ACCESSWIRE / February 11, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage…

After Three Years of Record Growth, Beam Continues Expansion with First Chief Product Officer

3 years ago

Fintech and digital health veteran brings two decades of experience building and scaling digital products.COLUMBUS, Ohio, Feb. 11, 2022 (GLOBE…

NFL LEGEND BRETT FAVRE AND ODYSSEY HEALTH, INC. INVOLVED WITH HUMAN TRIALS OF FIRST DRUG TREATMENT FOR CONCUSSION

3 years ago

NFL LEGEND BRETT FAVRE INVOLVED WITH HUMAN TRIALS OF FIRST DRUG TREATMENT FOR CONCUSSION NFL LEGEND BRETT FAVRE NFL LEGEND…

Adial Pharmaceuticals Announces Pricing of $10 Million Registered Direct Offering

3 years ago

CHARLOTTESVILLE, Va., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage…

Y-mAbs Announces Completion of Pre-BLA Meeting with FDA for Omburtamab

3 years ago

NEW YORK, Feb. 11, 2022 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical…

Amolyt Pharma to Participate at Three Upcoming Investor Conferences

3 years ago

LYON, France and CAMBRIDGE, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specialized in developing therapeutic…